QUREuniQure N.V.

$1B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+12.7% YoY

Gross Profit

-$11M-221.0% margin

Operating Income

-$20M-398.8% margin

Net Income

-$21M-430.4% margin

EPS (Diluted)

$-0.83

QoQ Revenue Growth

+48.8%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$21M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$158M

Total Liabilities

$131M

Stockholders' Equity

$27M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$4M	+12.7%
Gross Profit	-$11M	$4M	-354.1%
Operating Income	-$20M	-$21M	+6.1%
Net Income	-$21M	-$22M	+1.1%

QURE Q2 2017 Earnings — uniQure N.V. Revenue & Financial Results | Market Cap Arena